Metabolic Effects of Liothyronine Therapy in Hypothyroidism: A Randomized, Double-Blind, Crossover Trial of Liothyronine Versus Levothyroxine
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
CONTEXT: Levothyroxine (L-T(4)) therapy is based on the assumption that the conversion of T(4) into T(3) provides adequate amounts of active hormone at target tissues. However, in rodents, L-T(4) alone does not restore a euthyroid state in all tissues. Previous combination L-T(4)/liothyronine (L-T(3)) therapy trials focused on quality-of-life endpoints, and limited information is available on the effects on other measures of thyroid hormone action. OBJECTIVE: Our objective was to evaluate the efficacy of thyroid hormone replacement with L-T(4) or L-T(3) at doses producing equivalent normalization of TSH. PARTICIPANTS, DESIGN, AND SETTING: Fourteen hypothyroid patients participated in this randomized, double-blind, crossover intervention at the National Institutes of Health Clinical Center. INTERVENTIONS: L-T(3) or L-T(4) were administered thrice daily to achieve a target TSH from 0.5-1.5 mU/liter. Volunteers were studied as inpatients after 6 wk on a stable dose and at the target TSH. MAIN OUTCOME MEASURES: Serum thyroid hormones, lipid parameters, and indices of glucose metabolism were evaluated. RESULTS: No difference was observed in TSH between L-T(3) and L-T(4) treatments. L-T(3) resulted in significant weight loss [L-T(4), 70.6 ± 12.5, vs. L-T(3), 68.5 ± 11.9 kg (P = 0.009)] and in a 10.9 ± 10.0% decrease in total cholesterol (P = 0.002), 13.3 ± 12.1% decrease in low-density lipoprotein-cholesterol (P = 0.002), and an 18.3 ± 28.6% decrease in apolipoprotein B (P = 0.018). No significant differences were observed in high-density lipoprotein-cholesterol, heart rate, blood pressure, exercise tolerance, or insulin sensitivity. CONCLUSIONS: The substitution of L-T(3) for L-T(4) at equivalent doses (relative to the pituitary) reduced body weight and resulted in greater thyroid hormone action on the lipid metabolism, without detected differences in cardiovascular function or insulin sensitivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LT3 monotherapy administered three times daily produces stable TSH levels with continued fluctuations in T3 levels, such that they reach the upper end of the normal range with each of the three dose administrations (75,76).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [75]
In the citing paper
“Moreover, as judged by the length of time that it took over the course of the study to reach and maintain the goal TSH, it is too frequent a dosing regimen for participants to easily adhere to.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [75]
In the citing paper
“Sex hormone-binding globulin was also significantly increased, reflecting the hepatic impact of LT3 (75).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [75]
In the citing paper
“Treatment with LT3 alone was associated with lowered total and low-density lipoprotein cholesterol and decreased body weight, presumably reflecting the action of T3 on lipid and energy metabolism.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [75]
In the citing paper
“A crossover design is appealing because of the increase in statistical power due to the ability to perform paired analyses, as has been performed in prior studies (23,46,50,52,58,59,75,76,107).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [75]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1992) · PubMed · Cited by 33,716
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedüs, L., Vitti, P., Gharib, H., Papini, E., Paschke, R., et al. (2010) · Endocrine Practice · doi:10.4158/10024.gl · Cited by 1,088
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891 · cited 2×
“This is not surprising because type-2 deiodinase (30) is particularly active in the thyrotroph, and it is thought to play a major role in the hypothalamuspituitary-thyroid axis (27, 31).”
BackgroundThe modification of diet in renal disease study group
Beck, G. J., Berg, R. L., Coggins, C. H., Gassman, J. J., Hunsicker, L. G., Schluchter, M. D., & Williams, G. W. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90069-x · Cited by 818
Gharib, H., Papini, E., Valcavi, R., Baskin, H. J., Crescenzi, A., Dottorini, M. E., Duick, D. S., Guglielmi, R., Hamilton, C. R., Zeiger, M. A., et al. (2006) · Endocrine Practice · doi:10.4158/ep.12.1.63 · Cited by 681
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 1×
“tion within the normal laboratory reference limits (12).”
Background
Cited by
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Self-citationGarber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
“A potential role for L-triiodothyronine monotherapy in lieu of L-thyroxine monotherapy was recently raised by a small randomized, double-blind crossover intervention study done comparing L-triiodothyronine monotherapy with L-thyroxine monotherapy in patients with hypothyroidism (298).”
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
“Interestingly, providing hypothyroid human subjects with only T3 rather than T4, but keeping their TSH in the normal reference range, also results in reduced LDL cholesterol and slight weight loss (120).”
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Thyroid Hormones and the Metabolic Syndrome
Iwen, K. A., Schröder, E., & Brabant, G. (2013) · European Thyroid Journal · doi:10.1159/000351249 · Cited by 249
Laurberg, P., Knudsen, N., Andersen, S., Carlé, A., Pedersen, I. B., & Karmisholt, J. (2012) · European Thyroid Journal · doi:10.1159/000342994 · Cited by 220
Psychiatric and cognitive manifestations of hypothyroidism
Samuels, M. H. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000089 · Cited by 220
Hypothyroidism: etiology, diagnosis, and management
Almandoz, J. P., & Gharib, H. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.005 · Cited by 216
Overt and Subclinical Hypothyroidism: Who to Treat and How
Khandelwal, D., & Tandon, N. (2012) · Drugs · doi:10.2165/11598070-000000000-00000 · Cited by 199
Treatment for primary hypothyroidism: current approaches and future possibilities
Vaidya, B., Chakera, & Pearce (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s12894 · Cited by 199
Pearce, E. N. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328355cd6c · Cited by 175
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
Self-citationNewman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 172
Hoang, T. D., Olsen, C. H., Mai, V. Q., Clyde, P. W., & Shakir, M. K. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4107 · Cited by 151
Defending plasma T3 is a biological priority
Abdalla, S. M., & Bianco, A. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12538 · Cited by 147
Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124
Thyroid hormone therapy for hypothyroidism
Biondi, B., & Cooper, D. S. (2019) · Endocrine · doi:10.1007/s12020-019-02023-7 · Cited by 119
Thyroid Hormone Action and Energy Expenditure
Yavuz, S., Salgado Nunez del Prado, S., & Celi, F. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00423 · Cited by 95
Self-citationParadigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114
McAninch, E. A., Rajan, K. B., Miller, C. H., & Bianco, A. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01361 · Cited by 94
Carlé, A., Faber, J., Steffensen, R., Laurberg, P., & Nygaard, B. (2017) · European Thyroid Journal · doi:10.1159/000469709 · Cited by 93
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Samuels, M. H., Kolobova, I., Smeraglio, A., Peters, D., Purnell, J. Q., & Schuff, K. G. (2016) · Thyroid · doi:10.1089/thy.2015.0345 · Cited by 87
How does obesity affect the endocrine system? A narrative review
Poddar, M., Chetty, Y., & Chetty, V. T. (2017) · Clinical Obesity · doi:10.1111/cob.12184 · Cited by 86
Santoro, N. F., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., & Pinkerton, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1271 · Cited by 83
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · European Thyroid Journal · doi:10.1159/000512970 · Cited by 78
Self-citationPrinting T3 and T4 oral drug combinations as a novel strategy for hypothyroidism
Alomari, M., Vuddanda, P. R., Trenfield, S. J., Dodoo, C. C., Velaga, S., Basit, A. W., & Gaisford, S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.062 · Cited by 77
Endocrine effects of heat exposure and relevance to climate change
Hannan, F. M., Leow, M. K., LEE, J. K. W., Kovats, S. R., Elajnaf, T., Kennedy, S., & Thakker, R. V. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01017-4 · Cited by 74
A 2013 Survey of Clinical Practice Patterns in the Management of Primary Hypothyroidism
Burch, H. B., Burman, K. D., Cooper, D. S., & Hennessey, J. V. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1046 · Cited by 73
Impact of Overt and Subclinical Hypothyroidism on Exercise Tolerance: A Systematic Review
Lankhaar, J. A. C., de Vries, W. R., Jansen, J. A. C. G., ZELISSEN, P. M. J., & BACKX, F. J. G. (2014) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2014.930405 · Cited by 70
Pingitore, A., Mastorci, F., Piaggi, P., Aquaro, G. D., Molinaro, S., Ravani, M., Caterina, A. D., Trianni, G., Ndreu, R., Berti, S. L., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.12.020 · Cited by 64
Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism
Idrees, T., Palmer, S., Maciel, R. M. B., & Bianco, A. C. (2020) · Thyroid® · doi:10.1089/thy.2020.0153 · Cited by 58
THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
Wiersinga, W. M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0645 · Cited by 52
Single-Dose T3 Administration: Kinetics and Effects on Biochemical and Physiological Parameters
Jonklaas, J., Burman, K. D., Wang, H., & Latham, K. R. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000113 · Cited by 49
Hennessey, J. V., & Espaillat, R. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13062 · Cited by 49
Hypothyroidism After a Cancer Diagnosis: Etiology, Diagnosis, Complications, and Management
Carter, Y. M., Sippel, R. S., & Chen, H. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0237 · Cited by 46
Biondi, B., Bartalena, L., Chiovato, L., Lenzi, A., Mariotti, S., Pacini, F., Pontecorvi, A., Vitti, P., & Trimarchi, F. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0511-z · Cited by 44
Combination L-T3 and L-T4 therapy for hypothyroidism
Wartofsky, L. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000432611.03732.49 · Cited by 42
Jonklaas, J., & Burman, K. D. (2016) · Thyroid® · doi:10.1089/thy.2015.0629 · Cited by 41
“On the other hand, a study using three times daily administration of T3 in athyreotic patients that achieved steady T3 levels suggested that there may be hepatic effects of T3, as well as effects on body weight, without effects on heart rate or resting energy expenditure (23).”
Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2018) · Thyroid · doi:10.1089/thy.2018.0325 · Cited by 41
Samuels, M. H., Kolobova, I., Antosik, M., Niederhausen, M., Purnell, J. Q., & Schuff, K. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00224 · Cited by 37
Hypothyroidism and nonalcoholic fatty liver disease – a chance association?
Lugari, S., Mantovani, A., Nascimbeni, F., & Lonardo, A. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0047 · Cited by 38
Lankhaar, J. A. C., Kemler, E., Hofstetter, H., Collard, D. C. M., ZELISSEN, P. M. J., Stubbe, J. H., & BACKX, F. J. G. (2021) · Journal of Sports Sciences · doi:10.1080/02640414.2021.1940696 · Cited by 37
Samuels, M. H., Kolobova, I., Niederhausen, M., Purnell, J. Q., & Schuff, K. G. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01203 · Cited by 35
Shoemaker, T. J., Kono, T., Mariash, C. N., & Evans‐Molina, C. (2012) · Endocrine Practice · doi:10.4158/ep12086.ra · Cited by 35
Shultz, R. B., Wang, Z., Nong, J., Zhang, Z., & Zhong, Y. (2017) · Journal of Neural Engineering · doi:10.1088/1741-2552/aa6450 · Cited by 35
Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
Van Tassell, B., Wohlford, G. F., Linderman, J. D., Smith, S., Yavuz, S., Pucino, F., & Celi, F. S. (2019) · Thyroid® · doi:10.1089/thy.2019.0101 · Cited by 31
Self-citationSchlenker, E. H. (2012) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2012.02.007 · Cited by 30
Risks and safety of combination therapy for hypothyroidism
Jonklaas, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1182019 · Cited by 27
Forini, F., Nicolini, G., Pitto, L., & Iervasi, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00601 · Cited by 27
Changes in Body Weight after Treatment of Primary Hypothyroidism with Levothyroxine
Lee, S. Y., Braverman, L. E., & Pearce, E. N. (2014) · Endocrine Practice · doi:10.4158/ep14072.or · Cited by 26
Bjerkreim, B. A., Hammerstad, S. S., Gulseth, H. L., Berg, T. J., Omdal, L. J., Lee-Ødegård, S., & Eriksen, E. F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.816566 · Cited by 24
Köhrle, J., Lehmphul, I., Pietzner, M., Renko, K., Rijntjes, E., Richards, K., Anselmo, J., Danielsen, M., & Jonklaas, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00787 · Cited by 23
Metabolic Syndrome in Thyroid Disease
Iwen, K. A., Oelkrug, R., Kalscheuer, H., & Brabant, G. E. (2018) · Frontiers of hormone research · doi:10.1159/000485996 · Cited by 23
Dabbous, Z., Alowainati, B., Darwish, S., Ali, H. A., Farook, S., Malaheem, M. A., Abdalrubb, A., Gul, W., & Haliqa, W. A. (2019) · International Journal of Endocrinology · doi:10.1155/2019/9843961 · Cited by 22
Dumitrescu, A. M., Hanlon, E. C., Arosemena, M., Duchon, O., Ettleson, M., Giurcanu, M., & Bianco, A. C. (2022) · Thyroid · doi:10.1089/thy.2021.0304 · Cited by 20
Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design
Madan, R., & Celi, F. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00371 · Cited by 18
Self-citationSchmidt, U., Nygaard, B., Jensen, E. W., Kvetny, J., Jarløv, A., & Faber, J. (2013) · Endocrine Connections · doi:10.1530/ec-12-0064 · Cited by 17
Biondi, B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02302 · Cited by 17
Does Combination T4 And T3 Therapy Make Sense?
McDermott, M. T. (2012) · Endocrine Practice · doi:10.4158/ep12076.ra · Cited by 17
Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration
Galofré, J. C., Díez, J. J., Attanasio, R., Nagy, E. V., Negro, R., Papini, E., Perros, P., Žarković, M., Akarsu, E., Alevizaki, M. K., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02409-z · Cited by 16
Thyroid Hormone Effects on Glucose Disposal in Patients With Insulin Receptor Mutations
Kushchayeva, Y. S., Startzell, M. S., Cochran, E. K., Auh, S., Sekizkardes, H., Soldin, S. J., Kushchayev, S. V., Dieckmann, W., Skarulis, M. C., Sater, Z. A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz079 · Cited by 16
Self-citationThe pharmacological treatment of obesity: Past, present and future
Simonyi, G., Pados, G., Medvegy, M., & Bedros, J. R. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29317 · Cited by 16
Yavuz, S., Linderman, J. D., Smith, S., Zhao, X., Pucino, F., & Celi, F. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4196 · Cited by 15
Self-citationBiondi, B., Pucci, M., Pontieri, G., Formisano, P., & Esposito, R. (2023) · Thyroid · doi:10.1089/thy.2023.0135 · Cited by 15
Михайловна, З. С., Savelieva, L. V., & Fadeeva, M. (2013) · Obesity and metabolism · doi:10.14341/2071-8713-4826 · Cited by 15
Mutlu, S., Parlak, A., Aydoğan, Ü., Aydoğdu, A., Soykut, B., Akay, C., Sağlam, K., & Taşlıpınar, A. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0227-y · Cited by 14
Gietka-Czernel, M., Hubalewska-Dydejczyk, A., Kos-Kudła, B., Lewiński, A., Ruchała, M., Syrenicz, A., & Zgliczyński, W. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0065 · Cited by 13
Thyroid Function and Anthropometric Measures: A Systematic Review and Meta-Analysis
Dueñas, O. H. R., Xu, Y., Ikram, M. A., Peeters, R. P., Visser, W. E., & Chaker, L. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.11.011 · Cited by 12
Serum H-FABP levels in patients with hypothyroidism
Güneş, F., Aşık, M., Temız, A., Vural, A., Şen, H., Binnetoğlu, E., Bozkurt, N., Tekeli, Z., Erbağ, G., Ükinç, K., et al. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0612-7 · Cited by 12
Bahl, S., Taylor, P. N., Premawardhana, L. D., Stedman, M., Heald, A., Dayan, C. M., & Okosieme, O. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf449 · Cited by 11
Ceresini, G., Marina, M., Lauretani, F., Maggio, M. G., Serra, M. F., Meschi, T., Bandinelli, S., Ceda, G. P., & Ferrucci, L. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-0975-0 · Cited by 11
Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism
Brokhin, M., Danzi, S. E., & Klein, I. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00631 · Cited by 11
Belal, M. M., Youssef, A. R., Baker, H., Elalaky, N. A., Marey, A. A., Quaisy, M. A., & Rabea, E. M. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03526-z · Cited by 10
The complexity of the relationship between thyroid disease and body weight
Jonklaas, J. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01190-0 · Cited by 10
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism
Jonklaas, J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.12.003 · Cited by 10
Free Triiodothyronine and Cholesterol Levels in Euthyroid Elderly T2DM Patients
Strollo, F., Carucci, I., Morè, M., Marico, G., Strollo, G., Masini, M. A., & Gentile, S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/420370 · Cited by 10
Fabrication of Functional Cell Sheets with Human Thyrocytes from Non-Tumorous Thyroid Tissue
Huang, Y. G., Yamanouchi, K., Sakai, Y., Kuba, S., Sakimura, C., Morita, M., Kanetaka, K., Takatsuki, M., & Eguchi, S. (2019) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-019-00198-8 · Cited by 10
Mazza, A. D. (2025) · Cureus · doi:10.7759/cureus.90685 · Cited by 9
Phan, G. Q., Yavuz, S., Stamatouli, A. M., Madan, R., Chen, S., Grover, A. C., Nilubol, N., Bedoya, P., Trankle, C. R., Markley, R., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1522753 · Cited by 9
Self-citationBjerkreim, B. A., Hammerstad, S. S., Gulseth, H. L., Berg, T. J., Lee-Ødegård, S., & Eriksen, E. F. (2022) · Journal of Thyroid Research · doi:10.1155/2022/6423023 · Cited by 8
Sachmechi, I., Lucas, K. J., Stonesifer, L. D., Ansley, J. F., Sack, P., Celi, F. S., Scarsi, C., Lanzi, G., Wartofsky, L., & Burman, K. D. (2023) · Thyroid · doi:10.1089/thy.2023.0382 · Cited by 8
Self-citationВзаємозв’язок між гіпотиреозом та ожирінням
Yuzvenko, Т. Y. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.8.80.2016.89530 · Cited by 8
Guardado‐Mendoza, R. (2011) · Revista de Endocrinología y Nutrición · Cited by 8
Ruggenthaler, M., Grass, J., Schuh, W., Huber, C. G., & Reischl, R. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.05.039 · Cited by 8
Nice guideline on thyroid disease: where does it take us with liothyronine?
Leese, G. (2020) · Thyroid Research · doi:10.1186/s13044-020-00081-y · Cited by 7
Pepper, G. M., & Casanova-Romero, P. Y. (2014) · Cited by 7
Gottwald-Hostalek, U., & Tayrouz, Y. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2435460 · Cited by 6
Guglielmi, R., Mian, C., Novizio, R., Paoletta, A., Persichetti, A., Samperi, I., Scoppola, A., Bagnasco, M., Menis, E. D., Rimini, M. L. D., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02652-y · Cited by 6
The Influence of Thyroid Dysfunction on Body Composition and Weight Trajectory
Jonklaas, J. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.11.012 · Cited by 6
Subclinical Hypothyroidism; Natural History, Long-Term Clinical Effects and Treatment
Lee, J., & Youn, W. (2013) · InTech eBooks · doi:10.5772/53688 · Cited by 6
Jonklaas, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_19 · Cited by 6
Curia, S., Ng, F., Cagnon, M.-E., Nicoulin, V., & López‐Noriega, A. (2021) · Molecules · doi:10.3390/molecules26051438 · Cited by 5
Muscogiuri, G., Albertelli, M., Arnaldi, G., Barrea, L., Bellastella, G., Bonomi, M., Caputo, M., Caprio, M., Cignarelli, A., Gioia, L. D., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02862-y · Cited by 4
Azizi, F., Moeini, A. S. H., Mehran, L., Masoumi, S., Abdi, H., Foroutan, S. M., Saghafinia, A. E., & Amouzegar, A. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100395 · Cited by 4
Liothyronine use in primary hypothyroidism — current concepts
Concepción‐Zavaleta, M. J., Ildefonso-Najarro, S. P., Paz‐Ibarra, J., Fernández-Dávila, F. V., Condori, D. C. D.-G., Rivera-Fabián, K., Herrera-Cabezas, R. G., & Urteaga, L. A. C. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0093 · Cited by 4
Лечение первичного гипотиреоза: нерешенные вопросы
Моргунова, Т. Б., Madiyarova, M. S., & Fadeyev, V. V. (2015) · Clinical and experimental thyroidology · doi:10.14341/ket2015122-34 · Cited by 4
Kyriacou, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00005-1 · Cited by 4
Metadata
- Authors
- Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., & Pucino, F.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- Corresponding author
- Celi, Francesco S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-11
- Volume
- 96
- Issue
- 11
- Pages
- 3466-3474
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3205882
- OpenAlex
- W2057697685
- Cited by
- 125
- References
- 48
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 14 · 2017: 9 · 2016: 8 · 2015: 3 · 2014: 13 · 2013: 11 · 2012: 13
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (Z01-DK047057-02, Z01DK047057)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- liothyronine, levothyroxine, hypothyroidism, thyroid hormone replacement, lipid metabolism, cholesterol, apolipoprotein B, weight loss, insulin sensitivity, thyroid-stimulating hormone, cardiovascular function, exercise tolerance, glucose metabolism, thyroid hormone action, crossover trial, apolipoprotein A-I, apolipoprotein C
- MeSH terms
- Adult, Aged, Apolipoproteins B, Body Composition, Cholesterol, Double-Blind Method, Drug Administration Schedule, Female, Humans, Hypothyroidism, Male, Middle Aged, Quality of Life, Thyroid Hormones, Thyroxine, Triiodothyronine, Bone Density, Treatment Outcome, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.